Teleflex Incorporated (NYSE:TFX) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Teleflex Incorporated (NYSE:TFX) have earned an average rating of “Moderate Buy” from the eight analysts that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $260.14.

Several research analysts have recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. Truist Financial decreased their target price on Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a research report on Friday, May 3rd. Finally, Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $205.00 to $245.00 in a research report on Monday.

Teleflex Price Performance

Shares of NYSE TFX opened at $211.11 on Wednesday. Teleflex has a fifty-two week low of $177.63 and a fifty-two week high of $262.97. The business has a 50 day moving average price of $207.93 and a two-hundred day moving average price of $225.41. The company has a quick ratio of 1.41, a current ratio of 2.51 and a debt-to-equity ratio of 0.37. The firm has a market cap of $9.94 billion, a PE ratio of 33.89, a price-to-earnings-growth ratio of 2.04 and a beta of 1.13.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, beating analysts’ consensus estimates of $3.07 by $0.14. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The firm had revenue of $737.80 million during the quarter, compared to analyst estimates of $726.85 million. During the same quarter last year, the firm earned $3.09 EPS. Teleflex’s quarterly revenue was up 3.8% on a year-over-year basis. Sell-side analysts expect that Teleflex will post 13.75 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Wednesday, May 15th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend was Tuesday, May 14th. Teleflex’s dividend payout ratio (DPR) is 21.83%.

Institutional Trading of Teleflex

Several hedge funds have recently made changes to their positions in the stock. Riverview Trust Co bought a new stake in Teleflex during the 1st quarter valued at $31,000. Lindbrook Capital LLC raised its stake in Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 58 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its stake in Teleflex by 418.5% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock valued at $35,000 after acquiring an additional 113 shares in the last quarter. Pineridge Advisors LLC bought a new stake in Teleflex during the 4th quarter valued at $35,000. Finally, Janiczek Wealth Management LLC raised its stake in Teleflex by 227.1% during the 4th quarter. Janiczek Wealth Management LLC now owns 157 shares of the medical technology company’s stock valued at $39,000 after acquiring an additional 109 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.